Found: 23
Select item for more details and to access through your institution.
Mutations of the p16 gene product are rare in prostate cancer.
- Published in:
- Prostate, 1997, v. 30, n. 3, p. 188, doi. 10.1002/(SICI)1097-0045(19970215)30:3<188::AID-PROS7>3.0.CO;2-I
- By:
- Publication type:
- Article
Regulation of cyclic adenosine 3′:5′-monophosphate phosphodiesterases: Altered pattern in transformed myoblasts.
- Published in:
- Journal of Cellular Physiology, 1983, v. 116, n. 3, p. 336, doi. 10.1002/jcp.1041160311
- By:
- Publication type:
- Article
Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 3, p. 377, doi. 10.1002/(SICI)1097-0215(19970502)71:3<377::AID-IJC13>3.0.CO;2-D
- By:
- Publication type:
- Article
Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-β receptor type II.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 381, doi. 10.1007/s00262-002-0290-6
- By:
- Publication type:
- Article
Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1: a strategy for breast cancer gene therapy.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.
- Published in:
- Oncogene, 2002, v. 21, n. 8, p. 1187, doi. 10.1038/sj.onc.1205198
- By:
- Publication type:
- Article
Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27<sup>Kip1</sup>.
- Published in:
- Oncogene, 2001, v. 20, n. 33, p. 4466, doi. 10.1038/sj.onc.1204582
- By:
- Publication type:
- Article
Ad5/48 Hexon Oncolytic Virus Expressing sTGFβRIIFc Produces Reduced Hepatic and Systemic Toxicities and Inhibits Prostate Cancer Bone Metastases.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 8, p. 1504, doi. 10.1038/mt.2014.80
- By:
- Publication type:
- Article
AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma.
- Published in:
- Oncogene, 1998, v. 17, n. 10, p. 1261, doi. 10.1038/sj.onc.1202050
- By:
- Publication type:
- Article
Effects of adenovirus-mediated p16<sup>INK4A</sup> expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.
- Published in:
- Oncogene, 1998, v. 16, n. 2, p. 265, doi. 10.1038/sj.onc.1201493
- By:
- Publication type:
- Article
A recombinant adenovirus expressing p27<sup>Kip1</sup> induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells.
- Published in:
- Oncogene, 1997, v. 14, n. 19, p. 2283, doi. 10.1038/sj.onc.1201064
- By:
- Publication type:
- Article
The role of p27<sup>Kip1</sup> in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.
- Published in:
- Oncogene, 1997, v. 14, n. 17, p. 2111, doi. 10.1038/sj.onc.1201055
- By:
- Publication type:
- Article
p21<sup>Waf1/Cip1</sup> protects against p53-mediated apoptosis of human melanoma cells.
- Published in:
- Oncogene, 1997, v. 14, n. 8, p. 929, doi. 10.1038/sj.onc.1200897
- By:
- Publication type:
- Article
GENE THERAPY FOR CANCER.
- Published in:
- 2008
- By:
- Publication type:
- Book Review
Adenovirus replication–competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 8, p. 651, doi. 10.1038/sj.cgt.7700481
- By:
- Publication type:
- Article
Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 254, doi. 10.1038/sj.cgt.7700431
- By:
- Publication type:
- Article
The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.
- Published in:
- Cancer Gene Therapy, 1999, v. 6, n. 4, p. 291, doi. 10.1038/sj.cgt.7700059
- By:
- Publication type:
- Article
p53-dependent induction of heat shock protein 27 (HSP27) expression.
- Published in:
- International Journal of Cancer, 2000, v. 88, n. 2, p. 191, doi. 10.1002/1097-0215(20001015)88:2<191::AID-IJC7>3.0.CO;2-A
- By:
- Publication type:
- Article
A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis.
- Published in:
- Cell Death & Differentiation, 1999, v. 6, n. 4, p. 326, doi. 10.1038/sj.cdd.4400498
- By:
- Publication type:
- Article
p53 Regulates Human Insulin-Like Growth Factor II Gene Expression through Active P4 Promoter in Rhabdomyosarcoma Cells.
- Published in:
- DNA & Cell Biology, 1998, v. 17, n. 2, p. 125, doi. 10.1089/dna.1998.17.125
- By:
- Publication type:
- Article
Oncolytic Adenovirus Expressing Soluble TGFβ Receptor II-Fc-mediated Inhibition of Established Bone Metastases: A Safe and Effective Systemic Therapeutic Approach for Breast Cancer.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 9, p. 1609, doi. 10.1038/mt.2011.114
- By:
- Publication type:
- Article
132. Increased GFP Gene Delivery to Human Prostate Cancer Cells Using Trancomplementing Adenoviral Vectors.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S53, doi. 10.1016/j.ymthe.2006.08.153
- By:
- Publication type:
- Article
138. Targeted Adenoviral Vectors Expressing Soluble TGFβRIIFc for Breast Cancer Metastasis.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S55, doi. 10.1016/j.ymthe.2006.08.159
- By:
- Publication type:
- Article